Why Pediatric Adrenaline Doses Differ Between Anaphylaxis and Cardiac Arrest
The pediatric adrenaline dose is NOT the same for anaphylaxis and cardiac arrest—this is a dangerous misconception that has led to iatrogenic overdoses and life-threatening cardiac complications. 1
Correct Dosing by Indication
Anaphylaxis (Intramuscular Route)
- Dose: 0.01 mg/kg of 1:1000 concentration (maximum 0.3-0.5 mg) 2, 3
- Route: Intramuscular injection into the lateral thigh 2, 4
- Frequency: Repeat every 5-15 minutes as needed 2, 4
- Example: A 20 kg child receives 0.2 mg (0.2 mL of 1:1000 solution) 5
Cardiac Arrest (Intravenous/Intraosseous Route)
- Initial dose: 0.01 mg/kg of 1:10,000 solution (maximum 0.3 mg initially) 2
- Route: Intravenous or intraosseous 2
- Frequency: Repeat every 3-5 minutes during ongoing arrest 2
- Higher doses: 0.1-0.2 mg/kg (1:1000 solution) may be considered for refractory asystole or pulseless electrical activity 2
Why the Doses Differ
The fundamental difference lies in concentration, route, and physiologic goals:
- Anaphylaxis requires α-adrenergic effects to reverse vasodilation and reduce capillary permeability, but the patient has a perfusing rhythm 2, 6
- Cardiac arrest requires higher doses to achieve adequate coronary and cerebral perfusion pressure during chest compressions when there is no spontaneous circulation 2
- Intramuscular absorption from the thigh provides rapid, sustained plasma levels appropriate for anaphylaxis without the risk of cardiac complications 2, 4
Critical Safety Concern: The 1000-Fold Error Risk
A documented pattern of iatrogenic overdoses occurs when physicians confuse anaphylaxis dosing with cardiac arrest dosing. 1
Common Error Pattern:
- Physician intends to give anaphylaxis dose but administers 1 mg IV push (cardiac arrest dose) 1
- This represents a 10-100 fold overdose depending on patient weight 1
- Results in severe systolic dysfunction, potentially lethal cardiac complications 1
Contributing Factors:
- Both indications use "0.01 mg/kg" in pediatrics, but different concentrations (1:1000 vs 1:10,000) 2
- Need for rapid decision-making in critically ill patients amplifies error risk 1
- Many hospitals lack pre-filled, appropriately labeled IM epinephrine syringes 1
Special Considerations for Anaphylaxis Progressing to Cardiac Arrest
If anaphylaxis causes cardiac arrest, immediately switch to cardiac arrest dosing protocols. 2
- Standard resuscitative measures and immediate epinephrine administration take priority 2
- Use high-dose IV epinephrine with rapid progression: 1-3 mg IV over 3 minutes, then 3-5 mg, then 4-10 mg/min infusion in adults 2
- Pediatric cardiac arrest from anaphylaxis: 0.01 mg/kg (0.1 mL/kg of 1:10,000) every 3-5 minutes, with higher doses (0.1-0.2 mg/kg of 1:1000) for refractory arrest 2
- Prolonged resuscitation efforts are encouraged because outcomes are better in young patients with healthy cardiovascular systems 2
Preventing Medication Errors
Hospitals should stock clearly labeled, pre-filled intramuscular epinephrine syringes that are easily distinguished from IV formulations. 1
- The 1:1000 concentration (1 mg/mL) is for IM use in anaphylaxis 2, 4
- The 1:10,000 concentration (0.1 mg/mL) is for IV use in cardiac arrest 2, 4
- Adult epinephrine auto-injectors deliver 0.3 mg; pediatric auto-injectors deliver 0.15 mg 2
- A 0.1 mg auto-injector is available for patients weighing 7.5-15 kg 3
Key Pitfall to Avoid
Never give IV bolus epinephrine for anaphylaxis unless the patient is in cardiac arrest. 7 If IV access is established and the patient remains in shock (but not arrested), use 0.05-0.1 mg IV (1:10,000) or consider continuous infusion at 5-15 μg/min rather than IM dosing 2, 4. This represents only 5-10% of the cardiac arrest dose and requires close hemodynamic monitoring 2, 4.